VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM202 in Amyotrophic Lateral Sclerosis (ALS)

About Amyotrophic Lateral Sclerosis Amyotrophic lateral sclerosis (ALS), also ... ViroMed has assembled a diverse yet technologically and conceptually linked pipeline. Other research areas include therapeutic DNA vaccine for cancer, recombinant protein ...
News Type: 

Share this page with friends using the buttons below:

Add new comment